| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $70K | — | +214.8% |
| SG&A Expense | $729K | — | -42.1% |
| Operating Income | -$799K | — | +37.6% |
| Net Income | -$811K | — | +86.7% |
| EPS (Basic) | -$0.07 | — | +96.7% |
| EPS (Diluted) | -$0.07 | — | +96.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $2.7M | -11.9% | -57.2% |
| Total Assets | $2.7M | -11.9% | -57.2% |
| Current Liabilities | $736K | +145.7% | -21.4% |
| Total Liabilities | $849K | +110.9% | -65.0% |
| Stockholders' Equity | $1.9M | -30.4% | -52.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $579K | — | +151.8% |
| Financing Cash Flow | $196K | — | -96.3% |